Monopar Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,155 | -3,437 | -2,453 | -3,221 |
EBIT | -3,234 | -6,444 | ||
Net Income | -5,200 | -3,437 | -2,453 | -2,624 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,370 | -2,090 | -1,077 | -5,663 |
Cash | 61,833,552 | 127,677 | 39,501 | 39,711 |
Basic Shares | 6,692 | 7,123 | 6,998 | 6,987 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -16,704 | -16,161 | -8,831 | -10,515 |
EBIT | -31,748 | -8,401 | -10,536 | |
Net Income | -13,716 | -15,586 | -8,402 | -10,494 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,201,291 | -6,404 | -7,858 | -7,228 |
Cash | 61,833,552 | 45,816 | 7,266 | 8,186 |
Basic Shares | 7,411 | 11,483 | 14,511 | 12,718 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.61 |
2025-09-30 | -$0.48 |
2025-06-30 | -$0.35 |
2025-03-31 | -$0.38 |
